FBRX

Forte Biosciences (FBRX)

Forte Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:FBRX

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/14	05:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FBRX	Forte Biosciences Inc
2024/05/14	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FBRX	Forte Biosciences Inc
2024/02/17	06:16	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:FBRX	Forte Biosciences Inc
2024/02/15	06:54	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:FBRX	Forte Biosciences Inc
2024/01/06	07:27	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:FBRX	Forte Biosciences Inc
2024/01/04	06:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2024/01/04	06:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/12/21	00:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/12/16	08:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/12/13	09:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/12/09	09:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/12/09	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FBRX	Forte Biosciences Inc
2023/11/23	07:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/11/14	06:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FBRX	Forte Biosciences Inc
2023/10/04	05:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/10/04	05:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/27	05:16	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/21	06:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/21	06:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/21	06:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/21	06:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/21	06:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/21	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/21	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/15	05:00	Edgar (US Regulatory)	Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/14	23:50	Business Wire	ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual Meeting	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/11	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/09	05:36	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/07	05:31	Edgar (US Regulatory)	Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material	NASDAQ:FBRX	Forte Biosciences Inc
2023/09/07	04:15	Business Wire	Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s Boardroom	NASDAQ:FBRX	Forte Biosciences Inc